CrystalGenomics Inc - ESG Rating & Company Profile powered by AI
The analysis of CrystalGenomics Inc uses data from across the web and also from available filings by CrystalGenomics Inc. This Sustainability rating for CrystalGenomics Inc indicates its reporting of the United Nations Sustainable Development Goals. Comprehensive Sustainability analysis of CrystalGenomics Inc can be reached by registering for free.
CrystalGenomics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.5; made up of an environmental score of 1.6, social score of 1.6 and governance score of 1.3.
1.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2329 | Veritas Pharma Inc | 1.6 | Low |
| 2329 | Zhejiang Xinguang Pharmaceutical Co Ltd | 1.6 | Low |
| 2372 | CrystalGenomics Inc | 1.5 | Low |
| 2372 | Ambrx Biopharma Inc | 1.5 | Low |
| 2372 | Aikido Pharma Inc | 1.5 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does CrystalGenomics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes CrystalGenomics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes CrystalGenomics Inc report the average age of the workforce?
Sign up for free to unlockDoes CrystalGenomics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes CrystalGenomics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes CrystalGenomics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes CrystalGenomics Inc offer flexible work?
Sign up for free to unlockDoes CrystalGenomics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes CrystalGenomics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes CrystalGenomics Inc conduct supply chain audits?
Sign up for free to unlockDoes CrystalGenomics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes CrystalGenomics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes CrystalGenomics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes CrystalGenomics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes CrystalGenomics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes CrystalGenomics Inc disclose water use targets?
Sign up for free to unlockDoes CrystalGenomics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid CrystalGenomics Inc have a product recall in the last two years?
Sign up for free to unlockDoes CrystalGenomics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes CrystalGenomics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas CrystalGenomics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes CrystalGenomics Inc disclose parental leave metrics?
Sign up for free to unlockDoes CrystalGenomics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes CrystalGenomics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes CrystalGenomics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes CrystalGenomics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes CrystalGenomics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes CrystalGenomics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs CrystalGenomics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes CrystalGenomics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes CrystalGenomics Inc disclose its waste policy?
Sign up for free to unlockDoes CrystalGenomics Inc report according to TCFD requirements?
Sign up for free to unlockDoes CrystalGenomics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes CrystalGenomics Inc disclose energy use targets?
Sign up for free to unlockDoes CrystalGenomics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes CrystalGenomics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for CrystalGenomics Inc
These potential risks are based on the size, segment and geographies of the company.
CrystalGenomics, Inc., a biopharmaceutical company, discovers and develops structural chemoproteiomics-based drugs in Korea. Its lead development candidate is NSAID (CG100649), which is a tissue specific anti-inflammatory agent with cardiovascular, gastrointestinal, and renal safety profiles that has completed Phase IIa clinical trial. The company's drug candidates also include CG200745, a histone deacetylase inhibitor for cancer, which is in Phase I clinical trial; and CG400549, an antibiotic candidate for methicillin resistant staphylococcus aureus and vancomycin resistant staphylococcus aureus, which is in Phase I clinical trial. In addition, it offers cloning, expression, purification, and characterization of proteins of interest; and assay and structure services. The company has drug discovery collaborations with AstraZeneca, Daiichi-Sankyo, SBI-Biotech, Carna Biosciences, Yuyu Pharma, AmorePacific, Hanmi Pharmaceuticals, and ProQuest Investments. CrystalGenomics, Inc. was founded in 2000 and is headquartered in Seongnam, South Korea.